scispace - formally typeset
Journal ArticleDOI

The interferon signature in autoimmune diseases.

Lars Rönnblom, +1 more
- 01 Mar 2013 - 
- Vol. 25, Iss: 2, pp 248-253
Reads0
Chats0
TLDR
The observed IFN signature in several autoimmune diseases is a biomarker of active disease and is investigated as a tool when selecting treatment for individual patients.
Abstract
Purpose of reviewAn increased expression of type I interferon (IFN) regulated genes (an IFN signature) has been reported in blood and tissue cells from patients with SLE and other autoimmune diseases. We review the possible mechanisms behind the IFN signature as well as clinical and therapeutic cons

read more

Citations
More filters
Journal ArticleDOI

The innate immune perspective of autoimmune and autoinflammatory conditions.

TL;DR: A myriad of diseases has been linked with innate immune dysregulation, particularly regarding autoinflammatory ones, and a mini-review of these conditions will shed some light on these conditions.
Journal ArticleDOI

Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.

TL;DR: Clinical significance of both IFI16 protein and anti‐IFI16 antibodies in rheumatoid arthritis was investigated and leaking leads to loss of tolerance toward this self‐protein and the development of autoantibodies.
Journal ArticleDOI

T cells and cytokines in systemic sclerosis.

TL;DR: A better understanding of SSc pathogenesis will allow the development of novel therapeutic strategies targeting specific cell types and the pathways that are abnormally activated as well as the cytokines produced that may be directly involved with disease process.
Journal ArticleDOI

Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.

TL;DR: In this paper, the authors summarize those endogenous factors that can influence the type I IFN responses of plasmacytoid dendritic cells (pDCs) and thus might serve as possible therapeutic targets in pDC-associated diseases.
Journal ArticleDOI

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis.

TL;DR: This review focused on the activity of JAK inhibitors in the cardiovascular system of patients with RA and placed special emphasis on the modification of heart performance, progression of atherosclerosis, lipid profile disturbance, and risk of thromboembolic complications.
References
More filters
Journal ArticleDOI

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

TL;DR: Global gene expression profiling of peripheral blood mononuclear cells is used to identify distinct patterns of gene expression that distinguish most SLE patients from healthy controls, and identify a subgroup of patients who may benefit from therapies targeting the IFN pathway.
Journal ArticleDOI

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

TL;DR: Microarray analysis of blood cells reveals that immature granulocytes may be involved in SLE pathogenesis, and the IFN signature confirms the central role of this cytokine in Sle, using oligonucleotide microarrays.
Journal ArticleDOI

JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease

TL;DR: Not only have genome-wide association studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.
Related Papers (5)